The time course of subsequent hospitalizations and associated costs in survivors of an ischemic stroke in Canada

BMC Health Services Research

Volumn 6, Issue , 2006, Pages

  Caro, J Jaime ^a,b   Migliaccio Walle, Kristen ^a   Ishak, Khajak J ^c   Proskorovsky, Irina ^c   O'Brien, Judith A ^a  

^a CARO RESEARCH INSTITUTE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c Caro Research Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTERY DISEASE; ARTICLE; CANADA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; COST OF ILLNESS; FEMALE; FOLLOW UP; HEALTH CARE PLANNING; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; SURVIVAL; TRANSIENT ISCHEMIC ATTACK; BRAIN ISCHEMIA; COMPLICATION; ECONOMICS; EPIDEMIOLOGY; INCIDENCE; MIDDLE AGED; PROBABILITY; REGISTER; RISK ASSESSMENT; RISK FACTOR; STATISTICS AND NUMERICAL DATA; STROKE; SURVIVOR; TIME; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; COST OF ILLNESS; FEMALE; FOLLOW-UP STUDIES; HEALTH PLANNING; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROBABILITY; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SASKATCHEWAN; STROKE; SURVIVORS; TIME FACTORS;

EID: 33748597373     PISSN: 14726963     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-6-99     Document Type: Article

References (30)

1. Matchar DB: Health policy in stroke: translating what weknow into what we do. Stroke 2003, 34:370-371.
2. Hachinski V: Stroke: the next 30 years. Stroke 2002, 33:1-4.
3. Rudd AG, Matchar DB: Health policy and outcome research in stroke. Stroke 2004, 35:397-400.
4. Laloux P: Cost of acute stroke. A review. Acta Neurol Belg 2003, 103:71-77.
5. Grieve R, Dundas R, Beech R, Wolfe C: The development and use of a method to compare the costs of acute stroke across Europe. Age Ageing 2001, 30:67-72.
6. Payne KA, Huybrechts KF, Caro JJ, Green TJC, Klittich WS: Long term cost-of-illness in stroke: an international review. Pharmacoeconomics 2002, 20:813-825.
7. Dewey HM, Thrift AG, Mihalopoulos C, Carter R, Macdonell RA, McNeil JJ, Donnan GA: Lifetime cost of stroke subtypes in Australia: findings from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2003, 34:2502-2507.
8. Porsdal V, Boysen G: Costs of health care and social services during the first year after ischemic stroke. Int J Technol Assess Health Care 1999, 15:573-584.
9. Levy E, Gabriel S, Dinet J: The comparative medical costs of atherothrombotic disease in European countries. Pharmacoeconomics 2003, 21:651-659.
10. Public health and aging: hospitalizations forstroke among adults aged >= 65 years - United States 2000 [http://www.cdc.gov/mmwr/preview].
11. Malcolm E, Downey W, Strand LM, McNutt M, West R: Saskatchewan Health's linkable data bases and pharmacoepidemiology. Post Marketing Surveillance 1993, 6:175-264.
12. A guide to health coverage in Saskatchewan [http://www.health.gov.sk.ca/ mc_dp_skhealthbooklet.pdf]. consulted January 7, 2005
13. Caro JJ, Migliaccio-Walle K: Generalizing the results of clinical trials to actual practice: the example of clopidogrel therapy for the prevention of vascular events. Am J Med 1999, 107:568-572.
14. Lee ET, Wang JW: Statistical Methods for Survival Data Analysis 3rd edition. Hoboken: Wiley; 2003.
15. Life data analysis reference [http://www.weibull.com/lifedatawebcontents. htm]. consulted January 7, 2005
16. Therneau TM, Grambsch PM: Modeling Survival Data: Extending the Cox Model New York: Springer; 2000.
17. Fisher LD, Lin DY: Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 1999, 20:145-157.
18. Ontario Ministry of Health and Ontario Hospital Association. The Ontario Case Cost Project. The Ontario Case Cost Program Database 1995-96. Ottawa 1996.
19. FY 1999/2000 - Typical Cases file [http://www.occp.com]
20. Evers SM, Struijs JN, Ament AJ, van Genugten ML, Jager JH, van den Bos GA: International comparison of stroke cost studies. Stroke 2004, 35:1209-1215.
21. Vickrey BG, Rector TS, Wickstrom SL, Guzy PM, Sloss EM, Gorelick PB, Garber S, McCaffrey DF, Dake MD, Levin RA: Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease. Stroke 2002, 33:901-906.
22. Tu JV, Gong Y: Trends in treatment and outcomes for acute stroke patients in Ontario, 1992-1998. Arch Intern Med 2003, 163:293-297.
23. Caro JJ, Huybrechts KF: Stroke Treatment Economic Model (STEM). Predicting long-term costs from functional status. Stroke 1999, 30:2574-2579.
24. Moodie ML, Carter R, Mihalopoulos C, Thrift AG, Chambers BR, Donnan GA, Dewey HM: Trial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to assist priority setting in stroke. Stroke 2004, 35:1041-1046.
25. Migliaccio-Walle K, Caro JJ, Ishak K, O'Brien JA: Cost and Medical Care Consequences Associated with the Diagnosis of Peripheral Arterial Disease. Pharmacoeconomics 2005, 23:733-742.
26. Benesch C, Witter DM, Wilder AL, Duncan PW, Samsa GP, Matchar DB: Inaccuracy of the International Classification of Disease (ICD-9-CM) in identifying the diagnosis of ischemic and cerebrovascular disease. Neurology 1997, 49:660-664.
27. Leibson CL, Naessens JM, Brown RD, Whisnant JP: Accuracy of hospital discharge abstracts for identifying stroke. Stroke 1994, 25:2348-2355.
28. Rosamond WD, Folsom AR, Chambles LE, Wang CH, McGovern PG, Howard G, Copper LS, Shahar E: Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 1999, 30:736-743.
29. Goldstein LB: Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke 1998, 29:1602-1604.
30. Kokotailo RA, Hill MD: Coding of stroke and stroke riskfactors using International Classification of Diseases, Revisions 9 and 10. Stroke 2005, 36:1776-1781.